Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists
Award amount
$219,935Program and phase
SBIR · Phase IAward year
2013Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MOLECULAR TARGETING TECHNOLOGIES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Y2FNW7N1V267
- Solicitation number
- PA12-088
- Topic code
- NIGMS
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Phosphatidylserine-blocking nanoparticles as improved anti-thrombotic with reduced bleeding risk
- Instantaneous Tumor Spray for Real-Time Surgical Guidance
- Topic 368: Biotherapy of Brain Tumors by Radioiodinated SapC-DOPS Nanovesicles
- Sprayable, Prompt Color Changing Dye to Delineate Ovarian Cancer During Surgery
- Topical Drug Treatment of Cutaneous Leishmaniasis
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Three-Dimensional Spatio-Temporal Control of Lipid Nanoparticle Manufacturing for Improved Nucleic Acid Delivery
- Paradigm-changing, versatile, scalable and cost-effective technology for monthly injections of peptide drugs
- Project MATCH: Multi-spectral AI/ML powered Burn and Wound Evaluation Technology using a Cost-Effective Handheld Device.
- A versatile platform to isolate cells from three-dimensional samples after spatial and temporal profiling
- Development of an Educational Product for Accelerating Solutions for Commercialization and Entrepreneurial Development (ASCEND) in Western IDeA States
Research funding history
24 SBIR/STTR records share this UEI (1995–2023). Reported award amounts total $11,751,888. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Agriculture